Kulig Michael, Schulte Erika, Willich Stefan
Institute of Social Medicine, Epidemiology and Health Economics, Charité Hospital, Humboldt University of Berlin, D-10098 Berlin, Germany.
Eur J Heart Fail. 2003 Jun;5(3):327-35. doi: 10.1016/s1388-9842(03)00040-0.
Guidelines (GLs) for the management of heart failure (HF) are of great importance in order to define and disseminate therapeutic recommendations based on scientific evidence. The aim was to analyse and to compare the methodological quality of HF GLs as well as to evaluate the consistency of therapeutic recommendations.
Eleven international GLs for the management of chronic HF were identified by search of the internet, electronic databases and references of published literature. Their methodological quality was assessed by two different appraisal instruments: (1) according to the US National Guideline Clearinghouse (NGC) on a scale from 0 to 17 points, (2) according to the German Guideline Clearinghouse (Agency for Quality in Medicine, AQUMED) on a scale from 0 to 44 points. Clinical criteria for assessment of the consistency of the recommendations included diagnostic testing, pharmacological and non-pharmacological treatment.
The quality scores of the GLs varied substantially with a range of 1.5-15.5 points (NGC) and 8-30 points (AQUMED). The greatest variation was found in the dimensions "development" and "evidence". Only 3 of the 11 GLs (approximately 30%) were rated as methodologically well prepared. The recommendations on diagnostic procedures and medical management were rather consistent among the different GLs.
Published international GL recommendations on medical management of patients with chronic HF are broadly consistent. The methodological quality of the GLs, however, varies to a great extent. Improvement is needed in most methodological aspects, especially in the dimensions "evidence" and "applicability".
心力衰竭(HF)管理指南(GLs)对于基于科学证据定义和传播治疗建议至关重要。目的是分析和比较HF GLs的方法学质量,并评估治疗建议的一致性。
通过搜索互联网、电子数据库和已发表文献的参考文献,确定了11项慢性HF管理的国际GLs。它们的方法学质量由两种不同的评估工具进行评估:(1)根据美国国家指南交换中心(NGC),评分范围为0至17分;(2)根据德国指南交换中心(医学质量机构,AQUMED),评分范围为0至44分。评估建议一致性的临床标准包括诊断测试、药物和非药物治疗。
GLs的质量得分差异很大,NGC评分为1.5 - 15.5分,AQUMED评分为8 - 30分。在“制定”和“证据”维度上发现的差异最大。11项GLs中只有3项(约30%)在方法学上被评为准备充分。不同GLs之间关于诊断程序和医疗管理的建议相当一致。
已发表的关于慢性HF患者医疗管理的国际GL建议大致一致。然而,GLs的方法学质量差异很大。大多数方法学方面都需要改进,特别是在“证据”和“适用性”维度。